Tg(Krt15-cre/ERT2)1Johu
Transgene Detail
|
Symbol: |
Tg(Krt15-cre/ERT2)1Johu |
Name: |
transgene insertion 1, Joerg Huelsken |
MGI ID: |
MGI:3784521 |
Synonyms: |
K15-creERT2 |
Transgene: |
Tg(Krt15-cre/ERT2)1Johu Location: unknown
|
Alliance: |
Tg(Krt15-cre/ERT2)1Johu page
|
|
Strain of Origin: |
Not Specified
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(Krt15-cre/ERT2)1Johu expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Note |
Not Specified |
Krt15 |
|
|
|
|
Mutation details: 5 Kb of the Kr15 promoter was used to drive hair follicle bulge stem cell specific expression of a cre/ESR1 (ERT2) fusion. Cre expression is tamoxifen inducible. No line information was provided.
(J:133779)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Krt15
(species not specified)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:133779 Malanchi I, et al., Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature. 2008 Apr 3;452(7187):650-3 |
All: |
1 reference(s) |
|